Facebook
Twitter
LinkedIn
Forward
Overactive Bladder Update (2024)
COMPLIMENTARY CME VIRTUAL COURSES!
Launching in December, these new CME activities are aimed at updating advanced practice providers and allied health professionals alike on the latest advancements in OAB treatment. This FREE webinar and webcast feature a discussion with a vibrant panel of experts covering OAB guidelines, indications, tools and methodology for treatment and more!
Acknowledgements
Support provided by an independent educational grant from:
- Sumitomo Pharma America, Inc.
Target Audience
- APPs
Learning Objectives
After participating in this CME activity, participants will be able to:
- Adjust methods for diagnosis and treatment of Overactive Bladder (OAB) based on the clinical recommendations from the 2024 AUA/SUFU Guideline.
- Analyze the indications, mechanisms of action, and dosing regimens for OAB medications.
- Educate patients on what to expect with OAB treatment and how to report any adverse effects.
- Utilize appropriate tools and methods to assess the efficacy of OAB treatments in clinical practice.
- Effectively document the medical necessity for beta3 agonists and other OAB medications to insurance providers.